Thermo Fisher Scientific (TMO) PT Raised to $630 at Deutsche Bank

Deutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $630.00 (from $610.00) while maintaining a Buy rating.

The analyst comments "We are lowering 2025 EPS estimates by (3%) to reflect a more modest recovery in broader market conditions and updated outlook for Bioprocessing market growth at the low-end of historical range. We expect Thermo to reiterate its long-term growth construct of 7-9% at its upcoming Investor Day n We increase PT to $630 (from $610) based on 26.7x our 2025E EPS (from 25x) with upside to our conservative EPS estimates, balance sheet, and investor positioning supporting the stock."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Bernstein on China Online Beauty: Very Weak July Performance